FdaApplication

NDA 020323

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeNDA
approval_date1994-10-28

Products (5)

ProductActive ingredientStrengthDosage form
VIVELLEESTRADIOL0.025MG/24HRSYSTEM;TRANSDERMAL
VIVELLEESTRADIOL0.0375MG/24HRSYSTEM;TRANSDERMAL
VIVELLEESTRADIOL0.075MG/24HRSYSTEM;TRANSDERMAL
VIVELLEESTRADIOL0.05MG/24HRSYSTEM;TRANSDERMAL
VIVELLEESTRADIOL0.1MG/24HRSYSTEM;TRANSDERMAL

5 products